ms-553
mingsight pharma
['ms-553']
 presenting ms-553, a pkc-beta inhib in very heavily pre-tx cohort (median 4 prior lot) with 48% pr/pr-l as monotherapy. nice presentation! #ash22 
Associate clinical professor at UC Irvine focused on CLL/SLL and CHIP/CCUS/MDS. Animal and nature lover. Tweets are my own.